Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Federico Avila Moreno"'
Publikováno v:
Molecular Therapy: Oncology, Vol 32, Iss 1, Pp 200764- (2024)
Externí odkaz:
https://doaj.org/article/b501a568507f420aa38288919b1f4282
Autor:
Pedro Barrios-Bernal, Norma Hernandez-Pedro, Mario Orozco-Morales, Rubí Viedma-Rodríguez, José Lucio-Lozada, Federico Avila-Moreno, Andrés F. Cardona, Rafael Rosell, Oscar Arrieta
Publikováno v:
Pharmaceuticals, Vol 15, Iss 3, p 381 (2022)
The combination of metformin and TKIs for non-small cell lung cancer has been proposed as a strategy to overcome resistance of neoplastic cells induced by several molecular mechanisms. This study sought to investigate the effects of a second generati
Externí odkaz:
https://doaj.org/article/1de0dc7237c34fc6b7e461620507852a
Autor:
Juan José Mandoki, Manuel Meneses-Flores, Dolores Aguilar-Cazares, Federico Avila-Moreno, Jose Sullivan Lopez-Gonzalez, Heriberto Prado-Garcia
Publikováno v:
Clinical Immunology. 122:323-329
The role that inflammation plays in cancer is puzzling. In peripheral blood, TNF-alpha-producing monocytes (CD14+ cells) were compared among patients with lung cancer, patients with tuberculosis and healthy donors; also, in pleural effusion TNF-alpha
Autor:
Sandra Bajaña, Jose Sullivan Lopez-Gonzalez, Griselda Galindo-Rodríguez, Heriberto Prado-Garcia, Federico Avila-Moreno, Carmen Sánchez-Torres
Publikováno v:
Cancer Immunology, Immunotherapy. 55:598-611
Tumor-derived immunosuppressive factors contribute to the evasion of malignant cells from the immune response, partially by hampering dendritic cell (DC) differentiation. Here, we analyze whether soluble mediators released by the most frequent histol
Autor:
Gabriela Mercado-Célis, Camilo Molina Romero, Alejandro Aviles Salas, Federico Avila Moreno, Claudia Rangel Escareño, Alette Ortega Gómez, Oscar Arrieta, Andrés F. Cardona
Publikováno v:
Journal of Thoracic Oncology. 12:S1126-S1127
Autor:
Miguel A. Gómez-Lim, Carmen Sánchez-Torres, Federico Avila-Moreno, Abel Gutiérrez-Ortega, Luis Jorge Saucedo-Arias
Publikováno v:
Biotechnology and Bioengineering. 85:734-740
Interleukin 12 (IL-12) is a key heterodimeric cytokine produced by a variety of antigen-presenting cells, including dendritic cells, macrophages, and B cells. It displays a potent array of biological activities affecting natural killer (NK) and T cel
Autor:
David C. Christiani, Blanca Ortiz-Quintero, Abril Marcela Herrera-Solorio, Oscar Arrieta, Patricio Santillán-Doherty, Enrique Guzmán de Alba, Patricia Piña-Sánchez, Leonel Armas lopez, Federico Avila Moreno, Joaquín Zúñiga
Publikováno v:
Cancer Research. 77:682-682
Lung cancer remains the most progressive malignant disease strongly resistant to oncological therapies including platinum-derived cancer drugs and Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinases Inhibitors (TKIs). Homeobox-related gene (HOX)
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 63(5)
MicroRNAs (miRNAs) are endogenous small non-coding RNA molecules that regulate gene expression at the posttranscriptional level by blocking translation or inducing degradation of messenger RNA targets. It has been shown that miRNAs participate in a w
Autor:
Abel, Gutiérrez-Ortega, Federico, Avila-Moreno, Luis Jorge, Saucedo-Arias, Carmen, Sánchez-Torres, Miguel Angel, Gómez-Lim
Publikováno v:
Biotechnology and bioengineering. 85(7)
Interleukin 12 (IL-12) is a key heterodimeric cytokine produced by a variety of antigen-presenting cells, including dendritic cells, macrophages, and B cells. It displays a potent array of biological activities affecting natural killer (NK) and T cel
Autor:
Federico Avila-Moreno, Jorge Chavarrı́a-Garcés, Juan José Mandoki, Dolores Aguilar-Cazares, Jose Sullivan Lopez-Gonzalez, Alejandro Nieto-Rodrı́guez, Rosa Marı́a Rivera, Heriberto Prado-Garcia
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 38(2)
To determine the mechanisms involved in the evasion from TGF-beta growth regulation in the small cell lung carcinoma (SCLC) cell lines and the non-small cell lung carcinoma (NSCLC) cell lines, we studied: (a) production of TGF-beta1 and TGF-beta2; (b